Office for Technology Commercialization
http://www.research.umn.edu/techcomm
612-624-0550

Bringing together University clinical and technology experts from neurology, neurosurgery, neuroscience, neuromodulation research, biomedical engineering, radiology and magnetic resonance imaging research with industry.

Technology #neuroscience

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Managed By
Kevin Nickels
Technology Licensing Officer 612-625-7289
Neuroscience at UMN
Research
UMN has multiple active brain initiatives going back to the NIH Human Connectome Project: Lifespan where “Mapping of the Human Connectome” results were published in Science. Ongoing research at the Udall Center, Neuroengineering Laboratory and the University’s Department of Neurology continues the legacy of numerous publications and technology disclosures.
Activities
Centers and labs at UMN are active in scientific and clinical research in high field MRI, deep brain stimulation, electrodes for targeting and control of treatment algorithms and characterizing biomarkers by disease states are actively occurring through grants from Federal, State and private corporate funding sources. UMN researchers in labs across the university further technological advancements in neuroscience.
Resources
UMN offers a wide array of resources to patients, researchers, collaborators, scientists, engineers, startup companies, corporate partners and investors. The Office for Technology Commercialization (OTC) connects the industry to UMN researchers, sponsored research opportunities,  and new technologies that can be licensed. MN IP program allows corporate partners to advance research and position themselves strategically to license the technology. MnDRIVE is a landmark partnership between the University and the state of Minnesota that aligns research strengths to enable the state’s key and emerging industries to meet today's challenges.
Available Technologies
Neuroscience inventions developed by leading UMN scientists can be licensed by commercial entities for further development and commercialization. Emerging technologies and clinical insights flow from the Center for Magnetic Resonance Research, Udall Center of Excellence for Parkinson’s Disease Research, Department of Neurology, Neuromodulation Research Center and Biomedical Functional Imaging and Neuroengineering Laboratory.

This website is in development. Please send feedback to Carol Grutkoski at OTC.